To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

• Status: Active, not recruiting
• Trial end date: 2020-10-12
• Target enrollment: 0
• Participant gender: All

Summary

To Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: JW Pharmaceutical
• Treatments: Ezetimibe; Pitavastatin

Criteria

Inclusion Criteria:

• Patients with primary hypercholesterolemia

Exclusion Criteria:

• The subject not meet the specified LDL-C level